in 7 ra patients , a reduction in daily dosage of auranofin from 3 mg bid to 3 mg qd was correlated with a marked reduction ( 81 % -95 % ) in cell-associated gold , whereas a return to the 3 mg bid dose level resulted in a reinstatement of cell-associated gold .
C0004320
auranofin
C0018026
gold